Browsing byAuthorWatanabe, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)
2014-01-01An analytical framework for delirium research in palliative care settings: Integrated epidemiologic, clinician-researcher, and knowledge user perspectivesLawlor, PG; Davis, DHJ; Ansari, M; Hosie, A; Kanji, S; Momoli, F; Bush, SH; Watanabe, S; Currow, DC; Gagnon, B; Agar, M; Bruera, E; Meagher, DJ; De Rooij, SEJA; Adamis, D; Caraceni, A; Marchington, K; Stewart, DJ
2004-01-01A benchmark framework for risk managementPlaten, E; Akahori, J; Ogawa, S; Watanabe, S
2016-04-01Biotransformation of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegansWatanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S
2016-11-01Channel Simulation and Coded Source CompressionHsieh, MH; Watanabe, S
2016-06-01Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegansWatanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S
2016-04Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegansWatanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S
2015-12-17Fully quantum source compression with a quantum helperHsieh, MH; Watanabe, S
2013-09-01Global flood risk under climate changeHirabayashi, Y; Mahendran, R; Koirala, S; Konoshima, L; Yamazaki, D; Watanabe, S; Kim, H; Kanae, S
2019-06Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis.Pavasini, R; Serenelli, M; Celis-Morales, CA; Gray, SR; Izawa, KP; Watanabe, S; Colin-Ramirez, E; Castillo-Martínez, L; Izumiya, Y; Hanatani, S; Onoue, Y; Tsujita, K; Macdonald, PS; Jha, SR; Roger, VL; Manemann, SM; Sanchis, J; Ruiz, V; Bugani, G; Tonet, E; Ferrari, R; Volpato, S; Campo, G
2017-07-01In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-IsobutyrylfentanylWatanabe, S; Vikingsson, S; Roman, M; Green, H; Kronstrand, R; Wohlfarth, A
2018-07-01In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometryWatanabe, S; Kuzhiumparambil, U; Fu, S
2017-07-01Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegansWatanabe, S; Kuzhiumparambil, U; Nguyen, MA; Cameron, J; Fu, S
2021-01-01Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samplesLeong, HS; Watanabe, S; Kuzhiumparambil, U; Fong, CY; Moy, HY; Yao, YJ; Witting, PK; Fu, S
2015-03-01Oxidation of testosterone by permanganate and its implication in sports drug testingKuzhiumparambil, U; Watanabe, S; Fu, S
2014-01-01Practical assessment of delirium in palliative careLeonard, MM; Nekolaichuk, C; Meagher, DJ; Barnes, C; Gaudreau, JD; Watanabe, S; Agar, M; Bush, SH; Lawlor, PG
2015-09-28Source compression with a quantum helperHsieh, MH; Watanabe, S
2018-03-01Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) SpectroscopyWatanabe, S; Kuzhiumparambil, U; Fu, S